Coherus Oncology, Inc. (CHRS) › Total AssetsCoherus Oncology, Inc. (CHRS) — Total AssetsAnnual figures by period end, from SEC filings.2013-12-31: $47.45M2014-12-31: $187.22M2015-12-31: $212.38M2016-12-31: $178.49M2017-12-31: $162.61M2018-12-31: $99.47M2019-12-31: $408.93M2020-12-31: $841.65M2021-12-31: $679.33M2022-12-31: $480.85M2023-12-31: $629.60M2024-12-31: $448.53M2025-12-31: $258.34M$258.34M2013-12-31Total Assets (USD)2025-12-31Period endedTotal AssetsChange YoYSource filing2025-12-31$258.34M-42.4%2026-03-09Balance as of period end2024-12-31$448.53M-28.8%2026-03-09Balance as of period end2023-12-31$629.60M+30.9%2025-03-17Balance as of period end2022-12-31$480.85M-29.2%2024-03-15Balance as of period end2021-12-31$679.33M-19.3%2023-03-06Balance as of period end2020-12-31$841.65M+105.8%2022-02-23Balance as of period end2019-12-31$408.93M+311.1%2021-02-25Balance as of period end2018-12-31$99.47M-38.8%2020-02-27Balance as of period end2017-12-31$162.61M-8.9%2019-02-28Balance as of period end2016-12-31$178.49M-16.0%2018-03-08Balance as of period end2015-12-31$212.38M+13.4%2017-03-14Balance as of period end2014-12-31$187.22M+294.6%2016-02-29Balance as of period end2013-12-31$47.45M—2015-03-23Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)